Cargando…
Development of a Macrophage-Related Risk Model for Metastatic Melanoma
As a metastasis-prone malignancy, the metastatic form and location of melanoma seriously affect its prognosis. Although effective surgical methods and targeted drugs are available to enable the treatment of carcinoma in situ, for metastatic tumors, the diagnosis, prognosis assessment and development...
Autores principales: | Li, Zhaoxiang, Zhang, Xinyuan, Jin, Quanxin, Zhang, Qi, Yue, Qi, Fujimoto, Manabu, Jin, Guihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530689/ https://www.ncbi.nlm.nih.gov/pubmed/37762054 http://dx.doi.org/10.3390/ijms241813752 |
Ejemplares similares
-
Identification of Novel Hub Genes Associated with Psoriasis Using Integrated Bioinformatics Analysis
por: Yue, Qi, et al.
Publicado: (2022) -
Inhibitory Effect of Dihydroartemisinin on the Proliferation and Migration of Melanoma Cells and Experimental Lung Metastasis From Melanoma in Mice
por: Zhang, Qi, et al.
Publicado: (2021) -
The role of tumor-associated macrophages and soluble mediators in pulmonary metastatic melanoma
por: Xiong, Kaifen, et al.
Publicado: (2022) -
Development of an immune-related gene pairs index for the prognosis analysis of metastatic melanoma
por: Huang, Rong-zhi, et al.
Publicado: (2021) -
Dihydroartemisinin: A Potential Drug for the Treatment of Malignancies and Inflammatory Diseases
por: Yu, Ran, et al.
Publicado: (2021)